Revaccination with 7-valent pneumococcal conjugate vaccine elicits better serologic response than 23-valent pneumococcal polysaccharide vaccine in HIV-infected adult patients who have undergone primary vaccination with 23-valent pneumococcal polysac (Q42242523)

From Wikidata

Jump to navigation Jump to search

scientific article published on 15 January 2014

Language	Label	Description	Also known as
English	Revaccination with 7-valent pneumococcal conjugate vaccine elicits better serologic response than 23-valent pneumococcal polysaccharide vaccine in HIV-infected adult patients who have undergone primary vaccination with 23-valent pneumococcal polysac	scientific article published on 15 January 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24440112%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Revaccination with 7-valent pneumococcal conjugate vaccine elicits better serologic response than 23-valent pneumococcal polysaccharide vaccine in HIV-infected adult patients who have undergone primary vaccination with 23-valent pneumococcal polysaccharide vaccine in the era of combination antiretroviral therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24440112%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

based on heuristic

inferred from title

pneumococcal conjugate vaccine

1 reference

based on heuristic

inferred from title

Chien-Ching Hung

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24440112%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Yu-Chung Chuang

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24440112%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

author name string

Ching-Lan Lu

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24440112%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Sui-Yuan Chang

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24440112%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Wen-Chun Liu

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24440112%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Chin-Ting Su

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24440112%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Yi-Ching Su

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24440112%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Shu-Fang Chang

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24440112%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

language of work or name

0 references

publication date

15 January 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24440112%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

number of pages

5

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24440112%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

32

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24440112%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24440112%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1031-1035

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24440112%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Epidemiologic relation between HIV and invasive pneumococcal disease in San Francisco County, California

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.009

7 January 2021

Invasive pneumococcal disease in patients infected with HIV: still a threat in the era of highly active antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.009

7 January 2021

Declining incidence of invasive Streptococcus pneumoniae infections among persons with AIDS in an era of highly active antiretroviral therapy, 1995-2000.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.009

7 January 2021

Impact of pneumococcal vaccination on the incidence of pneumonia by HIV infection status among patients enrolled in the Veterans Aging Cohort 5-Site Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.009

7 January 2021

Reimmunization with 23-valent pneumococcal vaccine for patients infected with human immunodeficiency virus type 1: clinical, immunologic, and virologic responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.009

7 January 2021

Conjugate pneumococcal vaccine in HIV-infected Ugandans and the effect of past receipt of polysaccharide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.009

7 January 2021

A Randomized Clinical Trial Comparing Revaccination with Pneumococcal Conjugate Vaccine to Polysaccharide Vaccine among HIV‐Infected Adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.009

7 January 2021

23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.009

7 January 2021

A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.009

7 January 2021

Pneumococcal type 22f polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.009

7 January 2021

Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.009

7 January 2021

Conjugate and polysaccharide pneumococcal vaccines do not improve initial response of the polysaccharide vaccine in HIV-infected adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.009

7 January 2021

Enhanced antibody response to pneumococcal polysaccharide vaccine after prior immunization with conjugate pneumococcal vaccine in HIV-infected adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.009

7 January 2021

A 5-year longitudinal follow-up study of serological responses to 23-valent pneumococcal polysaccharide vaccination among patients with HIV infection who received highly active antiretroviral therapy*

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.009

7 January 2021

Immunogenicity of pneumococcal vaccine in renal transplant recipients--three year follow-up of a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.009

7 January 2021

IgG antibody to pneumococcal capsular polysaccharide in human immunodeficiency virus-infected subjects: persistence of antibody in responders, revaccination in nonresponders, and relationship of immunoglobulin allotype to response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.009

7 January 2021

Serologic response to primary vaccination with 7-valent pneumococcal conjugate vaccine is better than with 23-valent pneumococcal polysaccharide vaccine in HIV-infected patients in the era of combination antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.009

7 January 2021

Comparison of serologic responses to vaccination with one dose or two doses of 7-valent pneumococcal conjugate vaccine in HIV-infected adult patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.009

7 January 2021

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42242523&oldid=1775337805"